• Magazine
  • ENEWS
  • SUBSCRIBE
  • WEBINARS
  • PODCASTS
  • EBOOKS
    1. Home

    Novartis buys U.K. biotech firm, collaborates on Hep C treatment

    June 8, 2006
    The Manchester-based company specializes in treatments for infections usually acquired during hospital stays. Here's more about its founders. The Washington Post reports that Novartis will also collaborate with Human Genome Sciences on Albuferon, a treatment for Hepatitis C. -AMS
    The Manchester-based company specializes in treatments for infections usually acquired during hospital stays. Here's more about its founders. The Washington Post reports that Novartis will also collaborate with Human Genome Sciences on Albuferon, a treatment for Hepatitis C. -AMS

    About the Author

    pharmamanufacturing | pharmamanufacturing